EvolveImmune Therapeutics

EvolveImmune Therapeutics is an immuno-oncology company based in Branford, Connecticut, focused on developing first-in-category, multifunctional biotherapeutics to overcome cancer-driven immunodeficiency. Their proprietary EVOLVE™ platform utilizes a unique costimulatory approach to enhance T cell engagement with tumor cells, resulting in a more potent and durable anti-tumor response. This novel strategy addresses the limitations of traditional immunotherapy, such as low tumor immunogenicity and T cell exhaustion, by bypassing these challenges and conditionally activating adaptive immunity.

EvolveImmune's pipeline includes several programs targeting various solid tumors and hematological cancers, with a focus on developing precision immuno-oncology agents. Their lead programs, EV-104 and EV-105, are showing promising results in preclinical studies and are expected to enter clinical trials in 2024. The company has secured significant funding, including strategic investments from top-tier life science industry investors, to support their mission of transforming cancer treatment and improving patient outcomes.

EvolveImmune Therapeutics does not explicitly mention job flexibility on its website or in its job postings.

EvolveImmune Therapeutics offers competitive compensation and benefits for its employees, including top-tier health & wellness benefits and a 401K plan with a generous company match.

EvolveImmune Therapeutics is an immuno-oncology company dedicated to pioneering a new class of precision cancer medicines that deliver superior patient outcomes compared to current anti-cancer therapies. Their mission is to overcome cancer-driven immunodeficiency by developing first-in-category, multifunctional biotherapeutics designed to selectively regulate pathways that drive effective, durable anti-cancer immunity, ultimately transforming the lives of cancer patients and their loved ones.

EvolveImmune Therapeutics emphasizes a collaborative and supportive work environment, valuing the combined effort and individual contributions of its team. They strive to foster an innovative spirit, driven by curiosity and a relentless pursuit of improving the lives of cancer patients and their families.

EvolveImmune Therapeutics is committed to building a diverse and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique talents. The company strives to create a welcoming and equitable environment for everyone, regardless of their background, ethnicity, gender, sexual orientation, or any other protected characteristic. EvolveImmune believes that a diverse and inclusive workforce fosters creativity, innovation, and a strong sense of belonging, ultimately leading to a more successful and impactful company.